X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (349) 349
Patent (86) 86
Publication (38) 38
Book Review (26) 26
Conference Proceeding (20) 20
Book / eBook (8) 8
Book Chapter (6) 6
Newspaper Article (4) 4
Magazine Article (3) 3
Government Document (2) 2
Trade Publication Article (1) 1
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (190) 190
humans (171) 171
female (109) 109
male (85) 85
adult (75) 75
middle aged (73) 73
life sciences (69) 69
aged (53) 53
physics (52) 52
microbiology (50) 50
measuring (49) 49
testing (49) 49
animals (48) 48
infectious diseases (45) 45
human health and pathology (36) 36
abridged index medicus (35) 35
chemistry (31) 31
electricity (28) 28
metallurgy (28) 28
treatment outcome (28) 28
biochemistry (25) 25
cancer (25) 25
malaria (25) 25
analysis (24) 24
diagnosis (24) 24
general tagging of cross-sectional technologies spanning over several sections of the ipc (24) 24
general tagging of new technological developments (24) 24
human necessities (24) 24
hygiene (24) 24
parasitic diseases (24) 24
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (24) 24
adolescent (23) 23
health aspects (23) 23
hematology (23) 23
medical or veterinary science (23) 23
oncology (23) 23
organic chemistry (23) 23
parasitology (23) 23
preparations for medical, dental, or toilet purposes (23) 23
technologies for adaptation to climate change (23) 23
technologies or applications for mitigation or adaptation againstclimate change (23) 23
enzymology (22) 22
beer (21) 21
child (21) 21
compositions thereof (21) 21
culture media (21) 21
immunology (21) 21
microorganisms or enzymes (21) 21
mutation or genetic engineering (21) 21
propagating, preserving or maintaining microorganisms (21) 21
spirits (21) 21
vinegar (21) 21
wine (21) 21
aged, 80 and over (20) 20
peptides (20) 20
tropical medicine (20) 20
care and treatment (19) 19
measurement of nuclear or x-radiation (19) 19
endocrinology & metabolism (18) 18
erythrocytes (18) 18
france (18) 18
gastroenterology & hepatology (18) 18
investigating or analysing materials by determining theirchemical or physical properties (18) 18
parasites (18) 18
research (18) 18
research article (18) 18
risk factors (18) 18
medicine (17) 17
young adult (17) 17
epidemiology (16) 16
plasmodium falciparum (16) 16
spleen (16) 16
biomarkers (15) 15
basic electric elements (14) 14
electric solid state devices not otherwise provided for (14) 14
obstetrics & gynecology (14) 14
pregnancy (14) 14
semiconductor devices (14) 14
apparatus for conversion between ac and ac, between ac and dc,or between dc and dc, and for use with mains or similar powersupply systems (13) 13
control or regulation thereof (13) 13
conversion of dc or ac input power into surge outputpower (13) 13
conversion or distribution of electric power (13) 13
erythrocytes - parasitology (13) 13
generation (13) 13
mice (13) 13
prognosis (13) 13
breast cancer (12) 12
expression (12) 12
heating (12) 12
infections (12) 12
leishmaniasis, cutaneous - drug therapy (12) 12
multidisciplinary sciences (12) 12
mutation (12) 12
prospective studies (12) 12
travel (12) 12
usage (12) 12
[ sdv.mhep.mi ] life sciences [q-bio]/human health and pathology/infectious diseases (11) 11
blasting (11) 11
blood (11) 11
children (11) 11
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Media Commons - Audio Visual (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (395) 395
French (106) 106
German (24) 24
Chinese (2) 2
Italian (2) 2
Danish (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cités, ISSN 1299-5495, 2015, Volume 63, Issue 3, pp. 185 - 194
Journal Article
Cités, ISSN 1299-5495, 1/2015, Issue 63, pp. 185 - 193
Journal Article
Cités, ISSN 1299-5495, 01/2015, Volume 63, pp. 185 - 194
Degradation des systemes agricoles et des ressources halieutiques, diminution de la qualite et de la quantite des ressources hydriques, ou encore augmentation... 
Climate change | Treaties | Politics | North-South relations | Sustainable development
Journal Article
Hepatology, ISSN 0270-9139, 09/2015, Volume 62, Issue 3, pp. 737 - 750
Journal Article
2014, Pour mémoire, ISBN 9782912222466, 284
Book
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2016, Volume 11, Issue 6, pp. e0158297 - e0158297
Pegylated interferon α-2a (Peg-IFN-α) represents a therapeutic alternative to the prolonged use of nucleos(t)ide analog (NA) in chronic hepatitis B (CHB)... 
Recombinant Proteins - therapeutic use | T-Lymphocyte Subsets - immunology | Interferon-alpha - pharmacology | Hepatitis B, Chronic - immunology | Dendritic Cells - immunology | Humans | Middle Aged | Male | Polyethylene Glycols - therapeutic use | Viral Load | Hepatitis B Surface Antigens - blood | Lymphocyte Activation - immunology | T-Lymphocytes - metabolism | T-Lymphocyte Subsets - drug effects | T-Lymphocytes - drug effects | T-Cell Antigen Receptor Specificity - immunology | Killer Cells, Natural - immunology | Adult | Dendritic Cells - drug effects | Female | Hepatitis B, Chronic - blood | Dendritic Cells - metabolism | Polyethylene Glycols - pharmacology | Liver Function Tests | Interferon-alpha - therapeutic use | Hepatitis B Surface Antigens - immunology | Treatment Outcome | Recombinant Proteins - pharmacology | Hepatitis B, Chronic - virology | Phenotype | Hepatitis B, Chronic - drug therapy | T-Lymphocyte Subsets - metabolism | Biomarkers | T-Lymphocytes - immunology | Aged | Killer Cells, Natural - drug effects | Killer Cells, Natural - metabolism | DNA, Viral | Therapy | Laboratories | CD8 antigen | Helper cells | Chronic infection | Cytotoxicity | Viruses | Infections | Activation | Lymphocytes T | Adaptive control | Immunity | Hepatitis | α-Interferon | Immunology | Lymphocytes | Immunotherapy | Hepatology | Gastroenterology | Natural killer cells | Hepatitis B virus | Antigens | Immune response | Hepatitis B surface antigen | Cytokines | Dendritic cells | T cell receptors | Adaptive immunity | Patients | Seroconversion | CD4 antigen | Hepatitis B e antigen | Interferon | Viral infections | Hepatitis B | Index Medicus | Life Sciences | Human health and pathology | Hépatology and Gastroenterology | Cancer
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2016, Volume 11, Issue 6, pp. e0156200 - e0156200
Journal Article
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 7/2016, Volume 113, Issue 28, pp. 7804 - 7809
Journal Article
PLoS Neglected Tropical Diseases, ISSN 1935-2727, 11/2017, Volume 11, Issue 11, pp. e0006094 - e0006094
Background Complex cutaneous and muco-cutaneous leishmaniasis (CL and MCL) often requires systemic therapy. Liposomal amphotericin B (L-AmB) has a strong... 
AMBISOME | BRAZILIENSIS | PHARMACOKINETICS | MUCOSAL LEISHMANIASIS | MEGLUMINE ANTIMONIATE | EXPERIENCE | INFECTION | SODIUM STIBOGLUCONATE | FORMULATION | VISCERAL LEISHMANIASIS | PARASITOLOGY | TROPICAL MEDICINE | Humans | Middle Aged | Child, Preschool | Infant | Male | Leishmania - classification | Aged, 80 and over | Amphotericin B - administration & dosage | Leishmania - drug effects | Adult | Female | Retrospective Studies | Child | Leishmaniasis, Mucocutaneous - parasitology | Treatment Outcome | Leishmaniasis, Cutaneous - drug therapy | Amphotericin B - adverse effects | Travel | Leishmaniasis, Mucocutaneous - drug therapy | Antiprotozoal Agents - adverse effects | Leishmaniasis, Cutaneous - parasitology | Adolescent | Antiprotozoal Agents - administration & dosage | Aged | Amphotericin B - therapeutic use | Antiprotozoal Agents - therapeutic use | Care and treatment | Leishmaniasis, Cutaneous | Amphotericin B | Analysis | Travelers | Dosage and administration | Health aspects | Vector-borne diseases | Therapy | Countries | Medical services | Data processing | Infections | Duration | Leishmaniasis | Multivariate analysis | Patients | Consortia | Cutaneous leishmaniasis | Parasitic diseases | Travellers | Failure analysis | Healing | Lesions | Health risk assessment | Heart diseases | Index Medicus | Health | Leishmaniasis, Mucocutaneous | Life Sciences | Antiprotozoal Agents | Leishmania | Ecology, environment
Journal Article
Presse Medicale, ISSN 0755-4982, 02/2011, Volume 40, Issue 2, pp. 173 - 184
Because it relies on potentially toxic, difficult-to-handle, or expensive compounds the therapy of leishmaniasis is still a complex issue in 2010, especially... 
Journal Article